Isaac Manke - 07 Aug 2026 Form 4/A - Amendment Insider Report for OnKure Therapeutics, Inc. (OKUR)

Reporting relationship: Director
Issuer ticker: OKUR
Reported as of: 07 Aug 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 13 Aug 2026, 16:55:58 UTC
Original report date: 11 Aug 2026
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Rogan Nunn, by power of attorney

Key filing fact

Isaac Manke filed Form 4/A - Amendment for OnKure Therapeutics, Inc. (OKUR) on 13 Aug 2026.

Key facts

This page summarizes Isaac Manke's Form 4/A - Amendment filing for OnKure Therapeutics, Inc. (OKUR).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Aug 2026, 16:55.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001622769 Primary reporting owner

Manke Isaac

Relationship: Director
Address: C/O ONKURE THERAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Signature: /s/ Rogan Nunn, by power of attorney
Signature date: 13 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OKUR holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,300
Date: 07 Aug 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 15,300
Exercise price: $18.20
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The original Form 4, filed August 11, 2026, reported the disposition on August 7, 2026 of an option to purchase 15,300 shares of Class A Common Stock (the "Disposition"), and a corresponding acquisition of an option to purchase 15,300 shares of Class A Common Stock (the "Acquisition"), each in connection with an Option Repricing, as defined in footnote 3 of the original Form 4. The Disposition and Acquisition did not occur.

Footnote F2

1/36th of the shares subject to the option vested on November 4, 2024 and 1/36th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.